Spectral Medical Inc.

TSX:EDT.TO

Medical - Diagnostics & Research

Healthcare
$1.04 -1.45%

-$0.02 today

Market cap
$306.00M
Beta
0.23
P/E (TTM)
-10.5
EPS (TTM)
-$0.13
52W Low $0.77High $1.84

Volume 0.02M

Average 0.06M

EDT.TO Interest Income

Income earned on cash, deposits, and investments held by the company.

Spectral Medical Inc.TSX: EDT.TO

Interest Income · Q1 FY2026 · quarter ended Mar 2026

Interest income remains negative

Q1 FY2026 interest income was CA$0, compared with CA$0 a year earlier. Trailing-twelve-month interest income was CA$3.14M.

Context

  • Interest income amounted to 220.7% of revenue in FY2025, up 220.7 pp from a year earlier.
  • Interest income increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly interest income holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$784.25K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$0— QoQ
Last fiscal yearDec 2025
CA$5.39M— YoY
LTMMar 2026
CA$3.14M— YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Interest Income history

CAD · from the income statement

Latest · FY2025
5.39M CAD
Year-over-year change
—

Interest Income vs competitors

How EDT.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest income is compared through growth and share of revenue rather than absolute size.
  • Interest income amounts to 113.6% of revenue for EDT.TO, versus a peer median of 1.9%.
EDT.TO Competitors
Interest Income for EDT.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$10.78M CAD+22.3%-25.6%3.5%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$6.6M CAD-42.6%-32.5%2.1%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$3.14M CAD——113.6%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$2.1M USD+137.0%+36.2%—
PRN.TOProfound Medical Corp.LTM Mar 2026$996.93K USD-51.4%+0.9%5.3%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$892.63K USD-47.4%+60.1%1.7%
KSI.TOKneat.com, Inc.LTM Mar 2026CA$394.8K CAD-53.1%+472.6%0.6%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$0 USD-100.0%—0.0%
Peer median (excluding EDT.TO) —-47.4%+18.5%1.9%

Competitors are the stored peer set for EDT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2M1.67M1.6M2.29M2.44M
Cost of Revenue832K684K936K1.27M7.6M
Gross Profit1.16M983K662K1.02M(5.16M)
Gross Margin58.3%59.0%41.4%44.5%-211.1%
Research & Development004.68M3.97M4.33M
Selling, General & Admin7.01M8.64M11.29M11.62M11.73M
Operating Expenses7.86M9.43M12.08M13.02M6.53M
Depreciation & Amortization294K272K218K251K250K
EBITDA(6.38M)(7.18M)(13.96M)(11.97M)(11.44M)
EBITDA Margin-319.4%-430.7%-873.3%-523.5%-468.3%
Operating Income(6.66M)(8.45M)(11.42M)(12M)(11.69M)
Operating Margin-333.5%-506.7%-714.7%-524.8%-478.5%
Interest Income00005.39M
Interest Expense28K176K1.33M3.18M5.16M
Other Income / Expenses(40K)819K(4.09M)(3.4M)(36M)
Income Before Tax(6.96M)(7.63M)(15.51M)(15.4M)(47.69M)
Pre-Tax Margin-348.6%-457.6%-970.4%-673.4%-1952.9%
Income Tax Expense00000
Net Income(8.79M)(11.28M)(15.66M)(15.4M)(47.69M)
Net Margin-440.1%-676.7%-980.1%-673.8%-1953.0%
EPS (Basic)(0.03)(0.04)(0.06)(0.05)(0.17)
EPS (Diluted)(0.03)(0.04)(0.06)(0.05)(0.17)
Weighted Avg Shares252.46M269.84M278.56M281.08M287.21M
Weighted Avg Shares (Diluted)252.46M269.84M278.56M281.08M287.21M

Spectral Medical Inc.

TSX:EDT.TO

Intrinsic Alpha fair value

Locked

Current Price

$1.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.